Analysis

Mid-Day market update: Crude oil rises 1%; Esperion therapeutics shares drop following Q1 results

Midway through trading Wednesday, the Dow traded up 0.09% to 34,162.34 while the NASDAQ rose 0.53% to 13,705.72. The S&P also rose, gaining 0.30% to 4,177.13.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,513,400 cases with around 578,500 deaths. India confirmed a total of at least 20,664,970 cases and 226,180 deaths, while Brazil reported over 14,856,880 COVID-19 cases with 411,580 deaths. In total, there were at least 154,404,850 cases of COVID-19 worldwide with more than 3,229,350 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares rose 3.2% on Wednesday. Meanwhile, top gainers in the sector included Gran Tierra Energy Inc. GTE 10.62%, up 21%, and Oceaneering International, Inc. OII 18.1%, up 16%.

In trading on Wednesday, utilities shares fell 2.1%.

Top Headline

General Motors Company PFE reported better-than-expected earnings for its first quarter.

General Motors reported quarterly earnings of $2.25 per share, beating analysts’ estimates of $1.04 per share. The company’s quarterly sales came in at $32.50 billion, versus expectations of $32.67 billion.

General Motors said it sees FY21 adjusted earnings of $4.50-$5.25 per share, versus analysts’ estimates of $5.29 per share.

Equities Trading UP

Nemaura Medical Inc. NMRD 135.32% shares shot up 39% to $6.53 after the company reported an order for 200,000 sugarBEAT sensors.

Shares of Chiasma, Inc. CHMA 40.14% got a boost, shooting 45% to $4.11 after Amryt Pharma agreed to acquire the company in an all-stock combination.

Athenex, Inc. ATNX 22.64% shares were also up, gaining 41% to $5.24 after the company reported its acquired Kuur Therapeutics Inc, a portfolio company of IP Group plc, for $70 million upfront.

Equities Trading DOWN

Cocrystal Pharma, Inc. COCP 31.31% shares tumbled 32% to $1.45 after the company announced a $40 million bought deal offering of common stock.

Shares of Intrusion Inc. INTZ 28.82% were down 29% to $10.19 after the company reported worse-than-expected Q1 results. B. Riley FBR downgraded Intrusion from Buy to Neutral and lowered the price target from $30 to $13.5.

Esperion Therapeutics, Inc. ESPR 21.81% was down, falling 25% to $19.20 after the company reported worse-than-expected Q1 results. Stifel downgraded Esperion Therapeutics from Buy to Hold and lowered the price target from $37 to $20.

Commodities

In commodity news, oil traded up 1% to $66.34, while gold traded up 0.4% to $1,783.30.

Silver traded down 0.1% Wednesday to $26.545 while copper rose 0.1% to $4.5240.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 climbed 1.59%, the Spanish Ibex Index rose 1.28% and the German DAX 30 gained 1.79%. Meanwhile, the London’s FTSE 100 gained 1.45%, French CAC 40 rose 1.17% and Italy’s FTSE MIB surged 1.81%.

Producer prices in the Eurozone increased 1.1% in March, following a 0.5% rise in the earlier month. The IHS Markit Eurozone composite PMI edged higher to 53.8 in April from a preliminary reading of 53.7.

French composite PMI was revised lower to 51.6 in April from a preliminary reading of 51.7, while German composite PMI slipped to 55.8 in April from a preliminary level of 56.

Economics

Private businesses in the US hired 742,000 workers in April versus a revised 565,000 increase in March.

The IHS Markit services PMI increased to 64.7 in April versus a preliminary estimate of 63.1.

The ISM non-manufacturing PMI fell to 62.7 in April from 63.7 in the previous month.

US crude-oil inventories fell 8 million barrels last week, the Energy Information Administration said.

Federal Reserve Bank of Chicago President Charles Evans will speak at 3:00 p.m. ET.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.